March 31, 2026

Magnificent 7 Stocks: Where Investors Are Finding Growth in 2026

Table of contents

The 2024 market cycle delivered extraordinary returns from seven mega-cap technology names. However, structural cracks emerged as 2026 opened, and live performance data confirms the shift. Energy is up 33% year-to-date as of March 2026, powered by a 70% surge in oil prices driven by the US-Iran conflict. Meanwhile, software stocks are down 20%, and the Magnificent 7 Stocks are declining in aggregate as investors rotate capital toward earnings-revision-positive sectors.

This article evaluates where investors are finding growth beyond the Magnificent 7 Stocks in 2026. It covers AI enablers, sector rotation plays, undervalued large caps, and ETF diversification tools, grounding every recommendation in verified performance data, named company analysis, and institutional source attribution. Specifically, it addresses the following themes:

Why this group’s dominance is creating measurable concentration risk in passive index portfolios
Which sectors are outperforming big tech in 2026, backed by live performance data
The AI enabler names beyond Nvidia: Broadcom, Palantir, MongoDB, and AMD
Undervalued large-cap alternatives in healthcare and financials with comparable earnings quality
ETF tools for reducing this group’s index weight without abandoning broad market participation
A core-satellite framework for building a portfolio balanced between index breadth and rotation themes

What Are the Magnificent 7 Stocks, and Why Are Investors Moving Beyond Them?

The Magnificent 7 Stocks comprise Apple, Microsoft, Amazon, Alphabet, Tesla, Nvidia, and Meta. These seven companies drove a much larger share of S&P 500 returns through 2023 and 2024. Fidelity’s analysis confirms the group replaced FAANG and reflects a period when AI infrastructure and EV narratives dominated capital allocation. As a result, treating membership in this cohort as a permanent quality signal risks missing the leadership transitions that produce outsized returns.

From FAANG to the Magnificent 7 Stocks: How the Cohort Changed

FAANG comprised Facebook, Apple, Amazon, Netflix, and Google. The Magnificent 7 Stocks replaced it by adding Microsoft, Nvidia, and Tesla, and dropping Netflix. This shift reflects the pivot from consumer internet dominance to AI infrastructure and EV disruption. Furthermore, this grouping is no more permanent than FAANG was. The structural forces that elevated these names can rotate capital to a new cohort when growth gaps widen between legacy leaders and emerging names.

Why Concentration Risk Is the Core Argument for Diversifying Beyond the Magnificent 7 Stocks

The Magnificent 7 Stocks represented approximately 33% of total S&P 500 market capitalization as of March 2026, up from just 12.5% in 2016, according to Motley Fool research data. Consequently, an investor holding a standard cap-weighted S&P 500 index fund allocates one-third of equity exposure to just seven companies. Every new dollar into a cap-weighted fund automatically directs the largest portion to the largest names. Therefore, any simultaneous correction among these seven names flows directly into the broad index, amplifying downside for passive holders.

S&P 500 Sector Performance Snapshot: March 2026

Sector (March 2026)	YTD Performance	Primary Driver	Market Status
Energy	+33%	Oil price surge (+70%) fueled by the US-Iran conflict escalation.	LEADING
Healthcare	Positive	The GLP-1 drug innovation cycle is combined with defensive safety flows.	Outperforming
Semiconductors	+13% (Avg)	Steady demand for AI “picks-and-shovels” infrastructure.	Positive
Utilities	+10% (Feb)	Defensive rotation amid shifting interest rate expectations.	Improving
Materials	Lagging	Lack of structural catalysts; pressured by global growth concerns.	Underperforming
Tech (Software)	~-27%	AI Capex uncertainty and extreme sensitivity to “higher-for-longer” rates.	LAGGING
Financials	-11%	Yield curve flattening is creating significant net interest margin headwinds.	Lagging
S&P 500 (Broad)	-3%	Broad dispersion; the widest gap between winners and losers since 2002.	Mixed

Source: FactSet / S&P Dow Jones Indices; Investing.com. Energy remains the dominant YTD play as of late March 2026.

Why Investors Are Looking Beyond the Magnificent 7 in 2026

The rotation away from the Magnificent 7 Stocks in 2026 reflects a combination of valuation, earnings, and sector momentum signals. Three forces have come together: the group exceeded one-third of the S&P 500 market cap; high valuations masked uneven earnings participation; and energy surged 33% YTD as the only sector benefiting from the geopolitical shock premium. Sector dispersion reached its second-widest level since 2002 as of March 2026, with pairwise stock correlation at just 13%. This confirms that selective positioning is being rewarded over passive index holding.

What Is Driving the Sector Rotation in Practice

Healthcare emerged as a second key outperformer, driven by defensive inflows, the GLP-1 drug adoption cycle, and earnings entirely independent of AI capex spending. In addition, AI picks-and-shovels semiconductors (not application software) maintained an average +13% YTD gain, separating infrastructure exposure from the -20% software decline. The rotation carries fundamental conviction: Investopedia’s 2026 dip-buying analysis confirms selective institutional accumulation of non-Magnificent 7 names during market weakness.

The main rotation catalysts driving 2026 outperformance are as follows:

Energy (+33% YTD): Oil price surge (+70%) from the US-Iran conflict, creating an earnings revision cycle unique to the sector
Healthcare (positive YTD): GLP-1 drug supercycle via Eli Lilly plus defensive flows, combining growth with lower tech correlation
AI Semiconductors (+13% avg): Infrastructure and networking exposure, distinct from application software’s -20% decline
Utilities: Defensive positioning driving inflows amid heightened macro uncertainty

Are the Magnificent 7 Stocks Overvalued in 2026?

Valuation within the Magnificent 7 Stocks requires individual-stock analysis, since the seven names show significantly different forward earnings profiles. Some members command premium multiples on slowing revenue growth, while others sustain their valuation through accelerating revision cycles. In practice, the opportunity-cost question is more useful than the overvaluation question: which names outside this group meet the same quality criteria at materially lower entry multiples? That discipline consistently surfaces Broadcom, Palantir, Eli Lilly, Visa, and Mastercard as the strongest candidates.

The Next Generation: Top Stocks to Watch Beyond the Magnificent 7

MarketWatch and Interactive Investor jointly identify Broadcom, Palantir, AMD, MongoDB, Eli Lilly, Visa, Mastercard, and Salesforce as the most-cited names in the next-generation cohort. Each offers a distinct growth driver without the index-level crowding that Nvidia, Apple, or Microsoft carries in the cap-weighted S&P 500. Consequently, the shared quality is disciplined entry valuation, not sector or theme. Building exposure across four to six names from this cohort creates AI-era participation without single-point concentration risk.

Equity Name	Core Segment	Main Growth Driver	Risk Profile	Income Type	Theme
Broadcom	AI Networking/Chips	Custom ASIC design & hyperscale AI data center buildout.	Medium	Dividend	AI
Palantir	Enterprise AI SW	AIP deployment across government & commercial sectors.	Med-High	Growth Only	AI
MongoDB	AI Data Infra	Database platforms powering the generative AI app layer.	High	Growth Only	AI
AMD	Semis/GPU	Main GPU alternative to Nvidia; data center market share gains.	Med-High	Growth Only	AI
Eli Lilly	Pharma/GLP-1	GLP-1 obesity and diabetes therapeutic supercycle.	Medium	Low Dividend	Value
Visa	Payments	Transaction volume growth + AI-enhanced fraud prevention.	Low-Med	Dividend	Value
Mastercard	Payments	Cross-border transaction recovery and digital commerce scale.	Low-Med	Dividend	Value
Salesforce	Enterprise SW	AI CRM integration; focus on operating margin expansion.	Medium	Initiating Div.	Software
XLE ETF	Energy Sector	Geopolitical oil premium (US-Iran) + strict supply discipline.	Medium	High Yield	Rotation

Selection of 2026-relevant equities by driver and risk. Sources: MarketWatch; SEC Filings (Broadcom/Palantir).

Best AI Stocks Beyond Nvidia: The Enabler Universe

Broadcom and Palantir: Two Different AI Business Models

Broadcom generated $12.2 billion in AI revenue in fiscal year 2024, a 220% surge year-over-year, confirmed by SEC filings. By fiscal year 2025, total company revenue hit a record $64 billion, with Q4 FY2025 AI semiconductor revenue up 74% year-over-year. CEO Hock Tan guided Q1 FY2026 AI semiconductor revenue to double year-over-year to $8.2 billion. Broadcom’s custom ASIC chip design serves hyperscalers building proprietary silicon to reduce Nvidia dependency, a structural position with no current competitor at scale.

Palantir’s AI platform business, by contrast, reached an inflection point on the software side in 2025. Q4 2025 US commercial revenue grew 137% year-over-year to $507 million, with full-year FY2025 revenue totalling $4.48 billion, representing a 70% year-over-year increase in Q4. Moreover, Palantir issued FY2026 guidance of 61% revenue growth, and US commercial revenue guidance of 115% growth, well above consensus expectations. Its Rule of 40 score hit 127% in Q4, an industry-leading profitability metric that confirms the durability of its platform advantage.

MongoDB and AMD: Infrastructure and Hardware Plays

MongoDB’s Atlas database platform occupies a picks-and-shovels position in the AI stack. Specifically, every new AI application deployed requires a database infrastructure layer, making MongoDB a natural beneficiary of the broader AI buildout regardless of which application wins. AMD’s MI300X GPU, meanwhile, targets the same data center training market as Nvidia’s H100, creating a natural hedge within any AI-weighted allocation. Together, these four names deliver multi-position AI exposure that differs from Nvidia’s hardware moat, reducing single-name crowding risk across the most contested thematic trade.

When screening AI enabler names beyond the Magnificent 7, four factors matter most:

AI revenue specificity: Confirm measurable, growing revenue directly from AI infrastructure or deployment
Competitive moat durability: Assess whether the AI advantage is structural or easy for better-funded competitors to copy
Forward multiple vs growth rate: Compare forward P/E or P/S to consensus revenue growth before allocating
Single-name concentration: Maximum 5% per AI enabler, spread across at least two different positions

Undervalued Large-Cap Alternatives: Where Value Investors Look in 2026

Value discipline here means comparable earnings quality at a lower entry multiple. Interactive Investor identifies Eli Lilly, Visa, and Mastercard as the three most-cited large-cap alternatives. Each trades at lower forward multiples than the Magnificent 7 median while offering comparable or stronger earnings growth visibility. Eli Lilly’s GLP-1 drug supercycle creates a multi-year revenue runway protected by patent and regulatory barriers. Visa and Mastercard, on the other hand, operate payment duopolies with no credible infrastructure challenger, compounding high-margin fee revenue with global economic activity.

How to Screen for Quality Outside the Index Giants

Morningstar’s three-criteria framework covers forward earnings multiple vs growth rate, competitive moat durability, and balance sheet capacity. Applying this screen consistently surfaces meaningful opportunities outside the Magnificent 7 Stocks. Morningstar confirms Visa and Mastercard both qualify as wide-moat businesses, with structural advantages protecting above-average returns on invested capital for at least ten years. Healthcare earnings are independent of AI capex cycles; payment volumes correlate with GDP; and industrial reshoring revenues are contractually locked. This value cohort therefore delivers return potential and concentration risk reduction at the same time.

ETF Strategies for Reducing Magnificent 7 Exposure

Invesco’s RSP achieves the most direct structural dilution by weighting all 500 S&P 500 members equally at approximately 0.2%. This reduces the group’s combined weight from 33% to approximately 1.4%. No stock-selection overlay can replicate this rebalancing at a similar cost. In addition, sector ETFs in energy (XLE), healthcare (XLV), and industrials (XLI) layer targeted rotation exposure on top of the equal-weight core, giving investors access to the sectors leading the 2026 rotation.

For investors seeking full exclusion, Defiance’s XMAG ETF tracks the BITA US 500 ex Magnificent 7 Index, the first ETF mandated to exclude all seven names entirely. RSP plus two sector ETFs achieves dilution and broad market participation at the same time, in a three-instrument structure manageable with quarterly rebalancing. Investors do not, therefore, need to choose between complete exclusion and broad market coverage.

ETF Instrument	Ticker	Primary Function	Mag 7 Exposure	Portfolio Use Case
Invesco S&P 500 Equal Weight	RSP	Weighs all 500 members equally at ~0.2%, neutralizing cap-weight bias.	~1.4% Combined (vs ~33% in SPY)	Core Holding
Energy Select Sector SPDR	XLE	Targets the energy sector for pure rotation exposure and inflation hedging.	Zero Direct	Rotation Satellite
Health Care Select Sector SPDR	XLV	Defensive growth; captures GLP-1 drug cycle (Eli Lilly) and biotech.	Zero Direct	Defensive Satellite
Industrials Select Sector SPDR	XLI	Pure-play beneficiaries of reshoring, defense spending, and infrastructure.	Zero Direct	Rotation Satellite
Defiance Ex-Mag 7 ETF	XMAG	S&P 500 index methodology excludes all seven “Magnificent” names entirely.	ZERO (Full Exclusion)	Full Diversification

Sources: Fidelity; Motley Fool; Defiance ETFs. RSP dilutes concentration; XMAG removes it entirely for investors seeking to rotate out of 2025’s winners.

How to Build a Portfolio Beyond the Magnificent 7: A Core-Satellite Framework

Interactive Investor’s framework recommends three layers: 60-70% in an equal-weight core via RSP; 20-25% in rotation satellites across energy, healthcare, and industrials; and 10-15% in high-conviction AI enablers. A quarterly review compares earnings revision momentum, forward PE relative to growth rate, and flow data. Positions are rebalanced when any holding fails two of the three criteria in the same cycle. This framework converts the concentration argument into a structure you can actually maintain over time.

Starting With the Core and Building Out Step by Step

The practical sequence starts with the core layer and adds satellites one step at a time. First, replace any cap-weighted S&P 500 fund with RSP. This immediately reduces the combined weight of these seven names from 33% to approximately 1.4% without requiring any individual stock selection. From that base, target sectors with live 2026 earnings revision momentum, since both energy and healthcare qualify. Sector ETFs are the most cost-efficient way to add them. The AI enabler slot holds the highest-conviction position: two to three names from Broadcom, Palantir, MongoDB, or AMD, sized at 5% or below per name.

Portfolio Construction Checklist

Apply these steps before every satellite position addition:

Replace the cap-weight S&P 500 with RSP or an equivalent equal-weight instrument as the core
Add XLE energy sector ETF to capture 2026 rotation. Live data shows +33% YTD as of March 2026
Add XLV healthcare ETF for defensive growth, given the GLP-1 cycle and earnings independence from AI capex
Allocate to at least two AI enablers beyond Nvidia, such as Broadcom, Palantir, MongoDB, or AMD
Apply three-criteria screen: forward earnings multiple vs growth, moat durability, balance sheet
Review satellite positions quarterly against earnings revision momentum and institutional flows
Do NOT concentrate AI allocation in a single name. Maximum 5% per AI enabler position
Do NOT treat Magnificent 7 membership as a permanent quality signal without individual evaluation
Do NOT cite materials as a 2026 rotation leader. The sector is confirmed to be lagging in live data

How to Make Your Own Trading Plan!

Reading about sector rotation and AI enablers is one thing, but executing it is where most investors lose discipline. Understanding how to make your own trading plan is the crucial next step, as it converts the frameworks above into concrete rules you can actually follow when markets move against you.

Define Your Objective and Time Horizon.

Start with a single sentence: what are you trying to achieve and by when? Example: “Outperform the S&P 500 over a 24-month horizon by reducing Magnificent 7 concentration and capturing 2026 rotation themes.” Every position decision should pass through that filter.

Set Your Allocation Boundaries Before You Trade.

Using the core-satellite framework from this article as a starting point:

Core (60–70%): RSP or equivalent equal-weight instrument
Rotation satellites (20–25%): Sector ETFs in energy (XLE) and healthcare (XLV), validated by live earnings revision momentum
High-conviction individual names (10–15%): Maximum 5% per AI enabler; minimum two names from the non-Magnificent 7 cohort

Write these percentages down before placing a single order. Allocation boundaries are meaningless if they are set after a position has already run.

Define Your Entry Criteria

A vague conviction is not an entry signal. For each satellite or individual position, apply the three-criteria screen adapted from Morningstar’s framework:

Forward earnings multiple relative to the consensus growth rate
Competitive moat durability (wide, narrow, or none)
Balance sheet capacity to fund the growth thesis independently

A position only enters the portfolio when it clears all three. If it clears two out of three, it goes on a watchlist, not into the portfolio.

Set Your Exit Rules in Advance

The most common trading plan failure is the missing exit rule. For every position, define two exits before you buy:

Thesis exit: If the fundamental driver breaks — for example, energy pulls back below a specific earnings revision threshold, or an AI enabler loses its moat assessment — close the position regardless of price
Mechanical exit: If a satellite position grows beyond its maximum allocation boundary due to appreciation, trim back to target during the next quarterly review

Build a Quarterly Review Cadence.

Market leadership is rotating faster in 2026 than at any point since 2002, with pairwise stock correlation sitting at just 13%. A quarterly review compares three signals for each satellite position: earnings revision momentum, forward PE relative to growth rate, and institutional flow data. Any position failing two of the three signals in the same review cycle is replaced, not held on hope.

Write It Down and Commit to It

A trading plan you keep in your head is not a plan — it is a preference that changes with your mood. Document the objective, allocation boundaries, entry criteria, exit rules, and review schedule in a single file. Revisit it at the start of each quarter, not in the middle of a drawdown.

The rotation away from the Magnificent 7 in 2026 is rewarding investors with a process. A personal trading plan is what separates those who capture the move from those who react to it after the fact.

A Decade of Concentration: The Magnificent 7 and the S&P 500 in Context

The growth of the Magnificent 7 Stocks concentration over one decade is significant. From 12.5% in 2016 to 33.3% in March 2026, this cohort’s share of the S&P 500 nearly tripled in ten years. The same passive inflows that grew this concentration on the way up create the reverse risk on any sustained rotation. Understanding the full trajectory, therefore, is the starting point for every diversification decision going forward.

Market Period	Mag 7 Share of S&P 500	S&P 500 Full-Year Return	Mag 7 Performance Impact
2015	~12%	Baseline	Baseline Integration
2016	12.5%	+9.5%	+8.8% (Broad Participation)
2022	~28%	-19.4%	-41.3% (Tech Correction)
End-2024	~33%	+23.3%	Outsized Bullish Contribution
Dec 2025	34.3%	Strong Yearly Gain	Majority of Total S&P Return
Mar 2026	33.3%	-3% YTD	Declining Share & Sector Rotation

Evolution of the Magnificent 7 market cap concentration. Sources: Motley Fool (March 2026); Fidelity (end-2024); YCharts.

Related Topic	Connection to the Beyond-Mag-7 Framework (March 2026)
S&P 500 Concentration	The Mag 7 represented ~33% of market cap at end-2024, peaking at 34.3% in Dec 2025 before the current rotation. Source: Motley Fool, Fidelity.
AI Enablers (Non-NVDA)	Broadcom, Palantir, MongoDB, and AMD offer diversified AI exposure with significantly lower crowding risk. Source: MarketWatch, SEC Filings.
Energy Sector Rotation	Leading all sectors at +33% YTD, driven by the 70% oil price surge from the 2026 US-Iran conflict. Source: FactSet.
Equal-Weight Strategies	Instruments like RSP dilute Mag 7 weight from ~33% down to ~1.4% by weighting all 500 members equally. Source: Motley Fool, Fidelity.
FAANG vs. Magnificent 7	A shift in leadership: Mag 7 added Microsoft, Nvidia, and Tesla while dropping the lower-growth Netflix from the original FAANG. Source: Fidelity.
Large-Cap Alternatives	Eli Lilly, Visa, and Mastercard offer comparable earnings quality to Big Tech at more attractive forward multiples. Source: Interactive Investor.
Healthcare Defensive Growth	Top 2026 performer due to GLP-1 adoption and defensive inflows independent of the volatile AI capex cycle. Source: Investing.com.
Sector Dispersion 2026	Correlation at 13% (lowest in 98% of historical data) rewards active sector rotation over passive index holding. Source: FactSet, S&P DJI.
The “Magnificent 2”	Identifies extreme concentration even within the Mag 7, highlighting the fragility of momentum-only strategies. Source: TheStreet.
Buying the Dip (Non-Tech)	Investors shift toward accumulating fundamental-driven non-tech names during market pullbacks. Source: Investopedia.

How to Stay Positioned as Market Leadership Keeps Evolving Beyond the Magnificent 7

Investors who have worked through this article’s frameworks can move from passive acceptance of the Magnificent 7 Stocks concentration toward an active, data-driven approach. Three actions translate this directly into portfolio decisions: replace cap-weighted S&P 500 exposure with RSP; build AI exposure across at least two non-member enablers; and add at least one rotation sector position, validated by live data showing energy at +33% YTD as of March 2026.

As AI capex cycles mature, regulatory scrutiny of mega-cap technology intensifies, and interest rate paths remain uncertain, the case for positioning beyond the Magnificent 7 Stocks continues to strengthen. One important editorial note from earlier drafts: materials is NOT a 2026 outperformer. Energy is the only confirmed rotation leader, while healthcare and AI semiconductors provide the secondary outperformance thesis. The frameworks in this article, therefore, provide the foundation for revisiting positioning as market conditions evolve throughout the year.

Sources: Motley Fool (March 2026); Fidelity; Interactive Investor; MarketWatch; Morningstar; FactSet / S&P Dow Jones Indices; Broadcom Inc. SEC Form 8-K (Dec 2025); Palantir Technologies SEC Form 8-K (Feb 2026); Investing.com sector rotation analysis; Defiance ETFs (XMAG prospectus); ad-hoc-news.de (FactSet/J.P. Morgan data, March 24, 2026).

Join now

If you liked this post make sure to share it!